Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 6 recruiting now full pipeline small index

Facioscapulohumeral Muscular Dystrophy: full-pipeline trial registry

6 of 7 indexed Facioscapulohumeral Muscular Dystrophy trials are currently recruiting.

Corpus placement: #2,497 of 28,707 conditions by registered trial count.

Jump to open trials → Trial finder

7 US clinical trials · 6 currently recruiting · #2,497 of 28,707 conditions by registered trial count

Facioscapulohumeral Muscular Dystrophy: 7 US clinical trials tracked, 6 recruiting.

Facioscapulohumeral Muscular Dystrophy is the subject of 7 registered US clinical trials on ClinicalTrials.gov, 6 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Avidity Biosciences, running 1 of these trials.

Enrollment posture brief

Registry condition facioscapulohumeral-muscular-dystrophy

OPEN 6 | RECR 86% | LATE 1 | EARLY 1 | RANK #2497 | SPON 1

Volume-matched condition peers

Nearest open-share peer: Adenovirus (86% recruiting · 7 trials)

Facioscapulohumeral Musc (th…86%ACL Tear71.4%ACL57.1%Acute Myelogenous Leukemia42.9%Acne Scars28.6%
Open-enrollment share among volume-matched conditions near Facioscapulohumeral Muscular Dystrophy

Facioscapulohumeral Muscular Dystrophy lists 6 open slots (86% of 7 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Facioscapulohumeral Muscular Dystrophy on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Facioscapulohumeral Muscular Dystrophy is recruiting above its size-band peers.

    6 of 7 indexed trials (85.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Facioscapulohumeral Muscular Dystrophy trials is spread across many organizations.

    Avidity Biosciences accounts for 1 of 7 trials (14.3%). 7 distinct sponsors appear on at least one study for this condition label.

  3. Typical Facioscapulohumeral Muscular Dystrophy enrolment sits around 320 participants.

    Median target enrolment is 320 among the 7 trials that report a genuine target (sentinel values excluded). 2 of those (28.6%) plan for fewer than 100 participants.

  4. Facioscapulohumeral Muscular Dystrophy research leans observational.

    2 interventional and 5 observational studies make up this index (28.6% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 11Phase 31

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 3 1

Top Sponsors

Avidity Biosciences 1 trials
FSHD Society 1 trials
Epicrispr Biotechnologies 1 trials
Hugo W. Moser Research Institute at Kennedy Krieger 1 trials
University of Kansas Medical Center 1 trials
University of Rochester 1 trials
Massachusetts General Hospital 1 trials

Named interventions

Most-linked intervention names on Facioscapulohumeral Muscular Dystrophy records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

AOC-1020 Drug
1 trials
EPI-321 Biological
1 trials
Electrical Impedance Myography Device
1 trials
FSHD-specific functional rating scale Diagnostic test
1 trials
Observational Other
1 trials
Placebo Drug
1 trials

US sites by state

Facility locations filed on Facioscapulohumeral Muscular Dystrophy trials. A trial with sites in several states counts in each.

Maryland 4 trials
Massachusetts 4 trials
New York 3 trials
California 3 trials
Virginia 2 trials
Utah 2 trials
Pennsylvania 2 trials
Ohio 2 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Facioscapulohumeral Muscular Dystrophy page

7 registered trials, 6 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 6 Facioscapulohumeral Muscular Dystrophy trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Avidity Biosciences sponsors the most Facioscapulohumeral Muscular Dystrophy trials on record, review their full trial history before evaluating a specific study. See Avidity Biosciences's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Facioscapulohumeral Muscular Dystrophy condition card totals 7 registered trials; most-linked intervention AOC-1020; top US site state Maryland. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.